Extracorporeal photopheresis (ECP) is a well‐tolerated procedure that suppresses T‐
lymphocyte activity in a clonally‐specific way. It is an effective therapy that has established …

Extracorporeal photopheresis (ECP) is a cell-based immunotherapy that involves the
reinfusion of autologous leukocytes after exposure to psoralen and UVA. The treatment has …

The clinical use of extracorporeal photopheresis (ECP) for accepted indications such as
graft-versus-host disease, transplant rejection, and cutaneous T-cell lymphoma continues to …

Photopheresis, initially established as an effective treatment of cutaneous T‐cell lymphoma,
has in recent years also been used to treat chronic graft vs. host disease, heart transplant …

The immune system is tasked with the unique challenge of recognizing foreign pathogens
and damaged cells while at the same time preserving and protecting the integrity of “self” …

Introduction: Extracorporeal photopheresis (ECP) has been extensively used for the
treatment of immune-mediated diseases for over 20 years and has a consistent and …

Address correspondence to: Zelma C. Chiesa-Fuxench, Department of Dermatology,
University of Puerto Rico School of Medicine, PO Box 365067 San Juan, Puerto Rico 00936 …

Extracorporeal photopheresis (ECP) has been in clinical use for over three decades after
receiving FDA approval for the palliative treatment of the Sézary Syndrome variant of …

Extracorporeal photopheresis (ECP) is an autologous cell therapy that is widely used for the
treatment of T cell-mediated diseases. ECP has been FDA-approved for the treatment of …

Systemic autoimmune diseases (AID) have multiorgan, heterogeneous clinical
presentations and are characterized by dysregulation of the immune system …